Richard Ruedy - 29 Feb 2024 Form 4 Insider Report for Silk Road Medical Inc

Signature
/s/Mhairi Jones, by power of attorney
Issuer symbol
N/A
Transactions as of
29 Feb 2024
Net transactions value
-$66,750
Form type
4
Filing time
04 Mar 2024, 18:19:18 UTC
Previous filing
15 Sep 2023
Next filing
05 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Sale $66,750 -3,000 -1.7% $22.25 170,837 29 Feb 2024 Direct F1
transaction SILK Common Stock Award $0 +38,674 +23% $0.000000 209,511 01 Mar 2024 Direct F2
holding SILK Common Stock 70 29 Feb 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 09/08/2023
F2 The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. 25% of the shares shall vest on March 1, 2025 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.